Austin, TX 11/6/2007 12:02:16 AM
Speak with other shareholders about: (OTCBB: ABTG), (OTC: APNN), (OTCBB: ORMP) and (OTCBB: CVVUF).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.
----------------------------------------------------------
Chat real-time with other investors about this ABTG news release, by
clicking this link: http://www.stockwire.com/ABTG
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=ABTG
AMBIENT CORP (OTCBB: ABTG) "Up 29.63% on Friday"
Ambient Corporation engages in the design, development, commercialization, and marketing of broadband over power lines (BPL) equipment, technologies, and services in North America. Its BPL technology enables electric utilities and property owners to use its existing medium and low voltage distribution lines for the delivery Internet protocol-based services. The company offers smart grid utility applications, such as advanced metering, real time pricing, demand side management, and direct load control; and residential and multi-dwelling unit consumer broadband Internet access and voice over Internet protocol services to residential, industrial, and governmental customers. The company also offers engineering and installation services for BPL equipment. Ambient was founded in 1996 and is based in Newton, Massachusetts.
ABTG News:
November 2 - Ambient Closes $2.5 Million Private Placement
Company Remains Focused on Enabling Smart Grid Efficiencies
Ambient Corporation (OTCBB: ABTG), a leader in Broadband over Power Lines (BPL) solutions, announced that it has closed on an additional private placement of $2.5 million in principal amount of its newly issued 8% Senior Secured three-year Convertible Note from an institutional investor involved in Ambient's previous close, increasing the total 2007 investment into Ambient to $10MM.
The investor in this round, Vicis Capital Master Fund (Vicis), was issued the Note scheduled to mature in October of 2010, and which requires no repayment of principal until the maturity date. Interest on the Note does not begin accruing until July 2008; with first quarterly interest payment due in September 2008.
Commenting on the raise, John J. Joyce, President and CEO of Ambient, stated, "Ambient is pleased to have the backing of an institutional investor who shares, and supports, Ambient's long-term commercial vision. This additional infusion of capital allows Ambient to continue with our initiatives, and reach important milestones that are intended to mark the next phase of Ambient's growth."
Ambient is focused on enabling energy efficiency using proprietary BPL technology, which offers electric utilities a unique real-time view of the electrical grid distribution system and enables energy saving utility applications.
Shad Stastney, a partner with Vicis Capital, LLC, the investment manager for Vicis Capital Master Fund, said of the investment, "This latest investment in Ambient by Vicis further demonstrates our belief in the management of Ambient and the future for Ambient's technology. Our overall interest in Ambient and BPL technology is the potential it has to dramatically improve the efficiency with which utilities serve their customers and reduce their environmental footprint. We believe that Ambient is in a strong position to help with implementing solid solutions to every day issues faced by utilities."
Additional information relating to the Senior Secured Convertible Notes, the warrants, and related matters will be included in Ambient's Current Report on Form 8-K, which Ambient will be shortly filing with the Securities and Exchange Commission.
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. The offer and sale by Ambient of the securities described herein has not been registered under the Securities Act of 1933, and such securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
----------------------------------------------------------
Chat real-time with other investors about this APNN news release, by
clicking this link: http://www.stockwire.com/APNN
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=APNN
APPLIED NANOSCIENCE (OTC: APNN) "Up 28.57% on Friday"
Applied Nanoscience intends to commercialize a proprietary nanoparticle enhanced absorbent filter platform that filters out air borne bacteria and viruses, with the ability to kill the microoranisms upon contact with the filter.
APNN News:
November 2 - Applied Nanoscience Formulation Tests Successfully Against MRSA and Announces Scale-Up Progress With Successful Round of Testing Against Avian Influenza, Confirming Previous Testing
Applied Nanoscience Inc. (ANI) (OTC: APNN) announced that it has achieved highly successful test results for its proprietary silver nanoparticle formulation against methicillin resistant Staphylococcus aureus, or MRSA. The challenge produced a >99.99% reduction (4+log) in two minutes when coated on filter media and directly introducing the challenge organism. Testing was conducted at an independent, nationally recognized BSL-3 laboratory.
According to U.S. government researchers, MRSA, also known as the Superbug by the media, affects more 90,000 Americans annually. MRSA doesn't respond to penicillin-related antibiotics, which were previously used to treat them. The bacteria can be carried by healthy people, and can reside on their skin or in their nasal passages. While most MRSA cases are mild, they can turn into deadly flesh-destroying infections if they enter the bloodstream.
Separately, ANI and Emergency Filtration Products, Inc. (EFP) announced that they have completed another successful round of testing against the avian influenza strain H9N2. The test, which was designed to assess the efficacy of ANI's nanoparticle formulation when applied on filter media in a production environment, completely inactivated the strain in two minutes. Testing was conducted at a well-known independent BSL-3 laboratory.
ANI is working with EFP to conduct all testing necessary to support EFP's new 510k submission to the FDA for EFP's NanoMask. ANI will assist EFP to conduct the final phase of testing necessary prior to EFP's new submission to the FDA. EFP has a license to use ANI's proprietary silver nanoparticle formulation for personal protection masks and military uses.
----------------------------------------------------------
Chat real-time with other investors about this ORMP news release, by
clicking this link: http://www.stockwire.com/ORMP
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=ORMP
ORAMED PHARMACEUTICAL (OTCBB: ORMP) "Up 25.00% on Friday"
Oramed Pharmaceuticals is an Israeli-based company focused on the development of oral delivery solutions based on proprietary technology. Diabetes is one of the most rapidly growing diseases in the world and is one that requires constant and often unpleasant monitoring and drug therapy regimen. Oramed is currently developing an orally ingestible insulin capsule for the treatment of diabetes. The Company is also pursuing the development of oral delivery solutions for other drugs and vaccines. For more information, please visit www.oramedpharma.com.
ORMP News:
November 2 - Oramed's CEO to Present at Rodman & Renshaw's Ninth Annual Healthcare Conference On November 6, 2007
Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) Chief Executive Officer, Nadav Kidron, will present at Rodman & Renshaw's Ninth Annual Healthcare Conference taking place November 5 - 7, 2007, at the New York Palace Hotel.
Mr. Kidron will give the Company presentation on Tuesday, November 6 at 3:20 PM (EST) in the Kennedy II Room. Additional information regarding the conference can be found at http://www.rodmanandrenshaw.com/conferences?id=6.
Mr. Kidron will give a brief corporate overview and an update on the Company's latest clinical developments, including the recent successful completion of a Phase IA clinical trial with its oral insulin capsule.
To access a live audio webcast or the subsequent archived recording, log on to www.oramedpharma.com.
----------------------------------------------------------
Chat real-time with other investors about this CVVUF news release, by
clicking this link: http://www.stockwire.com/CVVUF
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=CVVUF
CANALASKA URANIUM (OTCBB: CVVUF) "Up 20.21% on Friday"
CanAlaska Uranium (OTCBB: CVVUF) is undertaking uranium exploration in seventeen 100%-owned and two optioned uranium projects in Canada's Athabasca Basin. Since September 2004, the Company has aggressively acquired one of the largest land positions in the region, comprising over 2.7 million acres (11,000+ sq. km or 4,200+ sq. miles). CanAlaska has expended over Cdn$24 million exploring its properties in the Athabasca Basin and has delineated multiple uranium targets. Initial drilling results from the West McArthur Project revealed uranium mineralization and significant zones of hydrothermal alteration, indicative of a favourable environment for uranium deposition. Active drilling and exploration has continued through the Summer, and Fall 2007 seasons at West McArthur and at 2 other significant projects. The Company's high profile in the prominent Athabasca Basin has attracted the attention of major international strategic partners. Among others, Mitsubishi Development Pty., a subsidiary of Japanese conglomerate Mitsubishi Corporation, has undertaken to provide CanAlaska C$11 mil. in exploration funding to earn 50% of the West McArthur Project. Agreements have also been executed with a Korean Consortium led by Hanwha Corporation to enter into C$19 million investment to earn 50% of the Cree East Project.
CVVUF News:
November 2 - CanAlaska Uranium Ltd.: New High Grade Uranium Assays from Summer Program
CanAlaska Uranium Ltd. (OTCBB: CVVUF) (the "Company") is presented further assay results from early summer sampling on its NE Wollaston Uranium project, where multiple uranium zones are defined in outcrop, and from surface boulders and subcrop. In August the Company was able to report on high grade uranium and uranium-rare earth mineralization which had been discovered and sampled very early in the season. The latest zone where we have laboratory assay values with significant mineralization is from the "Pitchblende Ridge" target area. At this occurrence, multiple float boulder samples are in excess of 1% U(3)O(8), and with values up to 16.98% U(3)O(8)
The Pitchblende Ridge zone of mineralization is located approximately 15 km north east of the first discovery zone of the season at "Crazy Train", where high-grade uranium / rare-earth mineralization was previously reported. A series of other uranium REE zones have also been outlined with this summer's work. These other zones stretch over the entire 80 km length of the NE Wollaston Property. In most cases, there has been insufficient time to carry out detailed work on the showings. However, future drill programs are planned for the zones of better response and geology.
The observed "boulder trains" are the trail of rubble and rocks dragged down-ice from surface mineral zones by the ancient ice sheet which covered most of the Canadian Shield. In some cases the mineralized boulders only extend for a short distance from the source, but there are occasional erratic boulders some distance from the original source. In the case of the boulder trains on the NE Wollaston project, most of them are considered to be close to the source, but this may be partially obscured by the many swamps and small lakes which cover the project area.
The Pitchblende Ridge boulder train trends up and over the topography, and originates and continues within swampy ground. A short airborne EM anomaly, is offset in the vicinity of postulated source of the boulder train, and is thought to be associated with a host for the mineralization. The samples are predominantly calc-silicate boulders, a number of which are have ancillary graphite mineralization with the uranium mineralization (up to 40% graphite). A mineralized zone with this graphite content would produce an airborne EM signature. The higher grade samples are small pitchblende nodules and appear to be associated with clay alteration.
All of the samples from the current program were submitted to one of two qualified Canadian Laboratories for analysis. Samples submitted to Saskatchewan Research Laboratories were analyzed for multi-element geochemistry and including uranium by tri-acid digestion and ICP. Samples submitted for assay for trace element geochemistry to Acme Laboratories in Vancouver BC, were analyzed by aqua regia digestion and ICP analysis. The samples were collected by CanAlaska field geologists under the supervision of Dr Karl Schimann, and were shipped in secure containment to the laboratories noted above.
The Company is now progressively receiving assay information for samples submitted for laboratory analysis during the summer. Further results for work carried out from August-October are expected over the next months. The awaited samples are from other surface mineralized zones on this property and other properties, as well as from the Company's summer drill programs. The laboratory delays have been significant, but results will be released as they are received and evaluated.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
